Daiichi Sankyo Chemical Pharma Odawara SiteProfile


This SiteProfile is a report containing information on 20 years of U.S. Food & Drug Administration inspections at the Daiichi Sankyo Chemical Pharma facility located in Odawara, Japan.

This report is updated through .

Site profiles provide key FDA inspection metrics as well as a comprehensive history of all FDA inspections of the site since the year 2001. Site profiles have proven to be useful as part of the due diligence process as companies evaluate a site for validation, acquisition, partnership, and/or benchmarking purposes. If you will be validating a large number of sites on an on-going basis, you should consider Enforcement Analytics or contact us at [email protected]

Product details

  • Daiichi Sankyo Chemical Pharma Odawara's metrics:
    • 483 issue rate, total inspections, total 483s
    • Links to Warning Letters issued, if any
  • Inspection details for each inspection (since 2001) conducted, including:
    • All investigators for each inspection
    • Industry of inspection and FDA office conducting the inspection
    • If a 483 was issued, and whether or not any inspections resulted in a Warning Letter.

Once you check out, you will receive an email (usually within minutes) with a link to download the site profile.